Individuals dealing with chronic back pain in Guro and surrounding areas can now access regenerative stem cell therapy ...
Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...
Astellas Pharma Inc.’s subsidiaries Astellas Institute for Regenerative Medicine (AIRM) and Universal Cells Inc. have entered into a research collaboration with Osaka University to develop a ...
Intradiscal injection of BRTX-100 during an outpatient procedure is expected to alleviate chronic low back pain arising from the damaged disc. The Food and Drug Administration (FDA) has granted Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results